Bernice Welles

Bernice Welles

Director/Miembro de la Junta en
American Life Science Pharmaceutical, Inc.
.
73 años
Health Technology
Consumer Services
Finance

Perfil

Bernice R.
Welles
is currently a Director at American Life Science Pharmaceutical, Inc., a Member at The Endocrine Society, and a Partner at IPF Management I SARL. Previously, she worked as the Chief Executive Officer at Alquest Therapeutics, Inc. from 2010 to 2013, Vice President-Product Development at Genentech, Inc. from 1995 to 2003, Vice President-Development at DiObex, Inc. from 2005 to 2008, Chief Medical Officer at Enject, Inc. from 2009 to 2013, and as a Venture Partner at MPM BioImpact, Inc. from 2003 to 2005.
She also served as an Independent Director at Spectrum Pharmaceuticals, Inc. and as Treasurer & Director at The San Francisco Food Bank.
Dr. Welles is a graduate of Brandeis University, Tufts University, Albany Medical College, and The Wharton School of the University of Pennsylvania.

Cargos activos de Bernice Welles

EmpresasCargoInicio
Director/Miembro de la Junta -
Corporate Officer/Principal 01/12/2010
Inversor de Capital Privado -

Antiguos cargos conocidos de Bernice Welles.

EmpresasCargoFin
Alquest Therapeutics, Inc.
Director Ejecutivo 01/01/2013
Director Técnico/Científico/I+D 01/12/2010
Corporate Officer/Principal 01/01/2008
Inversor de Capital Privado 01/04/2005
Corporate Officer/Principal 31/07/2003
Ver el detalle de la experiencia de Bernice Welles.

Formación de Bernice Welles.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

89

Relaciones de 1er grado

16

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas16

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Services

Commercial Services

Consumer Services

Health Technology

Consumer Services

Finance

Alquest Therapeutics, Inc.